PENTHROX Inhalation vapour Ref.[9285] Active ingredients:

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Medical Developments UK Limited, c/o Price Bailey LLP, Causeway House, 1 Dane Street, Bishops Stortford, Herts CM23 3BT, United Kingdom

Product name and form

PENTHROX 99.9%, 3 ml inhalation vapour, liquid.

Pharmaceutical Form

Inhalation vapour, liquid.

Clear, almost colourless, volatile liquid, with a characteristic fruity odour.

Qualitative and quantitative composition

Each bottle contains 3 ml of methoxyflurane 99.9%.

Excipients with known effect: Butylated hydroxytoluene (E321) (0.01% w/w).

List of Excipients

Butylated hydroxytoluene E321 (stabiliser)

Pack sizes and marketing

PENTHROX is supplied in the following presentations:

  • One bottle with a tear off tamper-evident seal (packs of 10)
  • Combination pack with one bottle of 3 ml PENTHROX, one PENTHROX Inhaler and one Activated Carbon (AC) chamber (packs of 1 or 10).

Not all pack sizes may be marketed.

Marketing authorization holder

Medical Developments UK Limited, c/o Price Bailey LLP, Causeway House, 1 Dane Street, Bishop’s Stortford, Herts CM23 3BT, United Kingdom

Marketing authorization dates and numbers

PL 42467/0001

27/10/2015

Drugs

Drug Countries
PENTHROX Australia, Canada, Cyprus, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Netherlands, New Zealand, Poland, Singapore, United Kingdom
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈